CEREVEL THERAPEUTICS HLDNG I's ticker is CERE and the CUSIP is 15678U128. A total of 109 filers reported holding CEREVEL THERAPEUTICS HLDNG I in Q1 2022. The put-call ratio across all filers is 0.45 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $7,428,687 | +51.0% | 233,680 | +15.8% | 0.02% | +47.1% |
| Q1 2023 | $4,920,268 | -22.8% | 201,733 | -0.2% | 0.02% | -26.1% |
| Q4 2022 | $6,377,420 | -23.5% | 202,201 | -31.5% | 0.02% | +43.8% |
| Q3 2022 | $8,338,283 | +26.0% | 295,066 | +17.9% | 0.02% | +33.3% |
| Q2 2022 | $6,618,125 | -25.9% | 250,312 | -1.9% | 0.01% | -7.7% |
| Q1 2022 | $8,933,926 | – | 255,180 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Anchor Investment Management, LLC | 100 | $4,240 | 0.00% |